Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (1998)	10/24/2007 12:26:38 AM
From: Jibacoa	Respond to of 3722

Steve, Yes, GHDX had a good spike today, although there was some profit taking AHs.<g> bigcharts.marketwatch.com They already had presented that data at the ASCO meeting in September biz.yahoo.com And on October 10 they also announced encouraging results from a study of Oncotype DX in postmenopausal women with node-positive, hormone receptor positive breast cancer conducted by the Southwest Oncology Group & said that they will present those results at the Annual San Antonio Breast Cancer Symposium in December. biz.yahoo.com GHDX has 4 Qs of better revenues & although it hasn't been able to cut is losses as yet, the pending 2Qs for this Yr are expected to be better, since the expected loss is around $1.04 vs the $1.18/shr in 2006 in spite that the loss in the first 6 months is $0.08 higher.<g> For 2008 the loss is expected to be cut substantially to around $0.25/shr. The short position is > 20x its DAV. The insiders reportedly hold > 20% & it has a good amount of institutional following.(The float is < 12M.<g>) finance.yahoo.com The stock needs to close above the resistance from the Dec-Jan Hs at the $24.68 level in order to make an all time H bigcharts.marketwatch.com Bernard